C. Ferrer Albiach

984 total citations
62 papers, 641 citations indexed

About

C. Ferrer Albiach is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, C. Ferrer Albiach has authored 62 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 25 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Radiation. Recurrent topics in C. Ferrer Albiach's work include Advanced Radiotherapy Techniques (23 papers), Radiation Therapy and Dosimetry (13 papers) and Prostate Cancer Treatment and Research (13 papers). C. Ferrer Albiach is often cited by papers focused on Advanced Radiotherapy Techniques (23 papers), Radiation Therapy and Dosimetry (13 papers) and Prostate Cancer Treatment and Research (13 papers). C. Ferrer Albiach collaborates with scholars based in Spain, France and United States. C. Ferrer Albiach's co-authors include V. Morillo, Felipe A. Calvo, Antonio J. Conde-Moreno, Javier Pascau, Claudio V. Sole, Isabel Tena, María Rosa Bella, Miguel Arístegui, Rocio García‐Carbonero and Felicia A. Hanzu and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, European Urology and International Journal of Environmental Research and Public Health.

In The Last Decade

C. Ferrer Albiach

59 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Ferrer Albiach Spain 14 253 200 199 171 147 62 641
Paola Pinnarò Italy 17 440 1.7× 335 1.7× 263 1.3× 244 1.4× 186 1.3× 42 1.0k
Lone Gothard United Kingdom 17 299 1.2× 315 1.6× 526 2.6× 240 1.4× 308 2.1× 29 1.1k
Joep G.H. van Roermund Netherlands 20 573 2.3× 157 0.8× 78 0.4× 162 0.9× 182 1.2× 41 914
Takashi Fukagai Japan 14 477 1.9× 32 0.2× 100 0.5× 138 0.8× 187 1.3× 67 727
Zachariah A. Allen United States 22 1.2k 4.6× 462 2.3× 122 0.6× 224 1.3× 96 0.7× 61 1.3k
D. Buchholz United States 12 349 1.4× 326 1.6× 207 1.0× 330 1.9× 365 2.5× 26 854
Tejinder Kataria India 17 519 2.1× 576 2.9× 381 1.9× 231 1.4× 77 0.5× 69 980
Peiman Haddad Iran 14 247 1.0× 48 0.2× 185 0.9× 206 1.2× 254 1.7× 55 623
A. Wygoda Poland 13 301 1.2× 106 0.5× 118 0.6× 145 0.8× 180 1.2× 55 664
Katsuyoshi Hashine Japan 14 412 1.6× 34 0.2× 93 0.5× 155 0.9× 126 0.9× 80 610

Countries citing papers authored by C. Ferrer Albiach

Since Specialization
Citations

This map shows the geographic impact of C. Ferrer Albiach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ferrer Albiach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ferrer Albiach more than expected).

Fields of papers citing papers by C. Ferrer Albiach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ferrer Albiach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ferrer Albiach. The network helps show where C. Ferrer Albiach may publish in the future.

Co-authorship network of co-authors of C. Ferrer Albiach

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ferrer Albiach. A scholar is included among the top collaborators of C. Ferrer Albiach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ferrer Albiach. C. Ferrer Albiach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández, Enrique, et al.. (2024). MARRTA: Risk matrix in advanced radiotherapy. Physica Medica. 127. 104846–104846.
2.
Morillo, V., et al.. (2023). Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction. Cancers. 15(16). 4163–4163. 6 indexed citations
3.
Morillo, V., et al.. (2022). The Usefulness of Adaptative Radiotherapy in Prostate Cancer: How, When, and Who?. Biomedicines. 10(6). 1401–1401. 4 indexed citations
4.
Morillo, V., et al.. (2022). The Impact of Frailty Screening on Radiation Treatment Modification. Cancers. 14(4). 1072–1072. 3 indexed citations
5.
Calvo, Felipe A., Javier Serrano, Mauricio Cambeiro, et al.. (2022). Intra-Operative Electron Radiation Therapy: An Update of the Evidence Collected in 40 Years to Search for Models for Electron-FLASH Studies. Cancers. 14(15). 3693–3693. 10 indexed citations
6.
Conde-Moreno, Antonio J., Fernando Durán López, A. Hervás, et al.. (2021). Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 111(3). S59–S59. 7 indexed citations
7.
García‐Carbonero, Rocio, Mercedes Mitjavila, Mercedes Robledo, et al.. (2021). Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clinical & Translational Oncology. 23(10). 1995–2019. 88 indexed citations
8.
Lorente, David, Casilda Llácer, Rebeca Lozano, et al.. (2021). Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate Cancer. European Urology. 80(5). 641–649. 5 indexed citations
9.
Contreras, Jorge, et al.. (2019). SEOR recommendations on the use of protons. Clinical & Translational Oncology. 22(6). 795–797.
10.
Pardo, J., et al.. (2019). Patient safety in radiation oncology in Spain: a need to change. Clinical & Translational Oncology. 22(5). 751–758. 5 indexed citations
11.
López‐Campos, Fernando, Virgilia Macias, Antonio J. Conde-Moreno, et al.. (2019). Time for radioimmunotherapy: an overview to bring improvements in clinical practice. Clinical & Translational Oncology. 21(8). 992–1004. 15 indexed citations
12.
Albiach, C. Ferrer, et al.. (2019). <p>Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain</p>. Journal of Pain Research. Volume 12. 2125–2135. 7 indexed citations
13.
Sole, Claudio V., et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 339–339. 8 indexed citations
14.
Morillo, V., et al.. (2016). Practical issues regarding angular and energy response in in vivo intraoperative electron radiotherapy dosimetry. Reports of Practical Oncology & Radiotherapy. 22(1). 29–36. 3 indexed citations
15.
Casas, Francesc, I. Henrı́quez, Xavier Maldonado, et al.. (2016). Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study. Clinical & Translational Oncology. 19(3). 373–378. 5 indexed citations
16.
Albiach, C. Ferrer, et al.. (2015). What can statistical process control show us about ionization chamber stability?. Radiation Measurements. 86. 1–7. 2 indexed citations
17.
Calvo, Felipe A., et al.. (2014). Intraoperative Radiotherapy for Gastrointestinal Malignancies: Contemporary Outcomes With Multimodality Therapy. Current Oncology Reports. 17(1). 419–419. 1 indexed citations
18.
Sole, Claudio V., Felipe A. Calvo, C. Ferrer Albiach, Javier Pascau, & H. Marsiglia. (2014). Bibliometrics of intraoperative radiotherapy. Strahlentherapie und Onkologie. 190(12). 1111–1116. 9 indexed citations
19.
Albiach, C. Ferrer, et al.. (2009). Theoretical aspects of implementation of kilovoltage cone-beam CT onboard linear accelerator for image-guided radiotherapy. Clinical & Translational Oncology. 11(8). 511–517. 2 indexed citations
20.
Albiach, C. Ferrer, et al.. (2003). Tratamiento multidisciplinario actual del cáncer de próstata metastásico. Actas Urológicas Españolas. 27(10). 767–782. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026